Glaukos Corp. (GKOS)
122.49
-3.85
(-3.05%)
USD |
NYSE |
Jun 10, 16:00
122.64
+0.15
(+0.12%)
Pre-Market: 20:00
Glaukos Price to Book Value : 10.65 for June 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 10.65 |
| June 09, 2026 | 10.99 |
| June 08, 2026 | 10.61 |
| June 05, 2026 | 10.87 |
| June 04, 2026 | 10.58 |
| June 03, 2026 | 9.885 |
| June 02, 2026 | 9.636 |
| June 01, 2026 | 8.970 |
| May 29, 2026 | 8.990 |
| May 28, 2026 | 9.265 |
| May 27, 2026 | 9.619 |
| May 26, 2026 | 10.06 |
| May 22, 2026 | 10.53 |
| May 21, 2026 | 12.17 |
| May 20, 2026 | 12.59 |
| May 19, 2026 | 12.25 |
| May 18, 2026 | 12.45 |
| May 15, 2026 | 12.61 |
| May 14, 2026 | 12.44 |
| May 13, 2026 | 12.02 |
| May 12, 2026 | 11.94 |
| May 11, 2026 | 11.85 |
| May 08, 2026 | 11.69 |
| May 07, 2026 | 11.74 |
| May 06, 2026 | 11.84 |
| Date | Value |
|---|---|
| May 05, 2026 | 11.68 |
| May 04, 2026 | 11.89 |
| May 01, 2026 | 12.28 |
| April 30, 2026 | 12.58 |
| April 29, 2026 | 10.24 |
| April 28, 2026 | 10.47 |
| April 27, 2026 | 10.65 |
| April 24, 2026 | 10.60 |
| April 23, 2026 | 10.54 |
| April 22, 2026 | 10.61 |
| April 21, 2026 | 10.65 |
| April 20, 2026 | 10.86 |
| April 17, 2026 | 10.89 |
| April 16, 2026 | 10.61 |
| April 15, 2026 | 10.56 |
| April 14, 2026 | 10.51 |
| April 13, 2026 | 10.42 |
| April 10, 2026 | 10.15 |
| April 09, 2026 | 10.42 |
| April 08, 2026 | 10.35 |
| April 07, 2026 | 10.04 |
| April 06, 2026 | 10.18 |
| April 02, 2026 | 9.837 |
| April 01, 2026 | 9.798 |
| March 31, 2026 | 9.364 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Globus Medical, Inc. | 2.318 |
| Insulet Corp. | 8.014 |
| Abbott Laboratories | 2.983 |
| AngioDynamics, Inc. | 2.953 |
| Alphatec Holdings, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 12.78 |
| PEG Ratio | -0.8759 |
| Price | 122.49 |
| Earnings Yield | -2.69% |
| Market Cap | 7.148B |
| PEGY Ratio | -0.8759 |